|
10127
|
IPOL
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
NA
|
NA
|
6 months and above
|
2-3 doses depending on volume and age
|
Intramuscular
|
NA
|
P1, P2 and P3
|
Monkey kidney cell
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/ipol-poliovirus-vaccine-inactivated-monkey-kidney-cell
|
NA
|
|
10128
|
KINRIX
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
2008
|
NA
|
4 - 6 years
|
5 doses
|
Intramuscular
|
NA
|
P1, P2 and P4
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/kinrix
|
NA
|
|
10129
|
PEDIARIX
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
GlaxoSmithKline
|
2002
|
NA
|
6 weeks - 6 years
|
3 doses at regimen of 2, 4, and 6 months of age.
|
Intramuscular
|
NA
|
P1, P2 and P5
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/pediarix
|
NA
|
|
10130
|
Pentacel
|
Poliomyelitis
|
Neurologic
|
Poliovirus
|
positive-sense, single-stranded RNA
|
Inactivated
|
Approved
|
Sanofi Pasteur
|
2008
|
NA
|
6 weeks - 4 years
|
4 doses at regimen of 2, 4, 6 and 15-18 months of age
|
Intramuscular
|
NA
|
P1, P2 and P6
|
NA
|
US FDA
|
NA
|
NA
|
NA
|
NA
|
NA
|
https://www.fda.gov/vaccines-blood-biologics/vaccines/pentacel
|
NA
|